Loss of miR-15/16 removes an inhibitor of BCL2 expression, and therefore promotes the constitutive survival of tumor B cells in vitro and leads to CLL development in mouse models [19,20]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.